Medical Device Network on MSN

Boston Scientific touts long-term data of SCS therapy

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Fast Company

The non-opioid solution driving the next era of pain management

In January 1999, Marianne, a nurse in Houston, Texas, was helping coworkers lift a patient when she felt a twinge in her back. At first, she believed the pain she felt was nothing more than a tweaked ...
WBJournal

Boston Scientific receives FDA approval for opioid-alternate back pain treatment

Marlborough medical technology firm Boston Scientific has received approval from the U.S. Food and Drug Administration for its WaveWriter Alpha spinal cord stimulator device to be used to treat low ...
Healio

FDA approves expanded indication of spinal cord stimulation therapy

Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication of Boston Scientific’s spinal cord stimulation system that treats ...